Ethyl 7-bromobenzo[d][1,3]dioxole-4-carboxylate, 95.0%, 1g

1,2,3,4-Tetrahydroquinaldine, 95.0%, 10g

(6-Chloro-1-methyl-1H-benzo[d]imidazol-2-yl)methanol, 95.0%, 250mg

2-(3-Bromophenoxy)-6-methylpyrazine, 98%, 5g

4-Methyl-1-pentyne>98.0%(GC)5mL

Éter monopropílico de propilenglicol, mín. 99 %, para síntesis, 5 l, envase de plástico.

Methyl 6-chloro-3-oxo-2,3-dihydropyridazine-4-carboxylate, 95.0%, 1g

1-(Tert-butyl) 2-methyl 3-oxopiperidine-1,2-dicarboxylate, 98%, 10g

Pomalidomide-PEG4-Ph-NH2, 98%, 100mg

3-BENZYLPIPERIDINE HCL, 95.0%, 250mg

Methyl 3-bromo-6-chloropyrazine-2-carboxylate, 95.0%, 1g

(2-(1H-Pyrrol-1-yl)phenyl)methanol, 95.0%, 5g

ethyl 5-amino-3-(trifluoromethyl)-1H-pyrazole-4-carboxylate, 98%, 1g